Status:
UNKNOWN
Spatial Location of Breast Cancer Local Recurrence After Mastectomy
Lead Sponsor:
Maastricht Radiation Oncology
Collaborating Sponsors:
Albert Schweitzer Hospital
Canisius-Wilhelmina Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Rationale:To improve the definition of the target volume for radiotherapy of the chestwall after different types of mastectomy, the exact localization of regions at risk for a local recurrence should ...
Detailed Description
Rationale:To improve the definition of the target volume for radiotherapy of the chestwall after different types of mastectomy, the exact localization of regions at risk for a local recurrence should ...
Eligibility Criteria
Inclusion
- Age 18 years and more at the time of breast cancer diagnosis.
- Proven histology of first invasive breast cancer
- Mastectomy as a surgical procedure for breast cancer (regardless of perioperative treatment).
- Having a local recurrence, as primary event
- reast cancer diagnosis in the period 2003-2008.
Exclusion
- Non-epithelial histology.
- Primary metastatic breast cancer.
- Mastectomy for breast cancer recurrence after earlier breast conserving therapy.
- Synchronous breast cancer.
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT06130111
Start Date
September 1 2021
End Date
January 1 2024
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastro
Maastricht, Limburg, Netherlands, 6229ET